NexGen TM Tibia Clinical Outcomes Study

NACompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

October 3, 2017

Primary Completion Date

March 30, 2023

Study Completion Date

March 31, 2023

Conditions
OsteoarthritisRheumatoid ArthritisTraumatic ArthritisPolyarthritisCollagen Disorders and/or Avascular Necrosis of the Femoral CondylePost-traumatic Loss of Joint ConfigurationModerate Valgus, Varus, or Flexion Deformities
Interventions
DEVICE

NexGen TM Monoblock Tibia

Primary cementless tibia total knee arthroplasty

DEVICE

NexGen TM Modular Tibia

Primary cementless tibia total knee arthroplasty

Trial Locations (7)

19104

University of Pennsylvania, Philadelphia

28374

Pinehurst Surgical Clinic, Pinehurst

46158

Franciscan Health, Mooresville

47362

Henry County Orthopedics and Sports Medicine, New Castle

63017

Woods Mill Orthopedics, Ltd, Chesterfield

80033

Cornerstone Orthopaedics & Sports Medicine, P.C., Wheat Ridge

90502

LA BioMed at Harbor-UCLA Medical Center, Torrance

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Zimmer Biomet

INDUSTRY

NCT03272373 - NexGen TM Tibia Clinical Outcomes Study | Biotech Hunter | Biotech Hunter